Hemogenyx Pharmaceuticals
UK - LondonPharmaceutical
Focus: Hemogenyx Pharmaceuticals is a UK-based public company focused on blood stem cell and bone marrow transplantation therapies, with a specialized pipeline in cell therapy and neurology indications. The company operates at an early clinical stage with minimal commercial scale.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Hemogenyx Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Hemogenyx Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Anti-FLT3 CAR-T cells
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)Clinical Trials (1)
NCT06786533Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML
Phase 1Help build intelligence for Hemogenyx Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.